Annual Short Term Debt
$961.80 M
+$750.80 M+355.83%
31 December 2023
Summary:
Novo Nordisk A/S annual short term debt is currently $961.80 million, with the most recent change of +$750.80 million (+355.83%) on 31 December 2023. During the last 3 years, it has fallen by -$271.06 million (-21.99%). NVO annual short term debt is now -53.83% below its all-time high of $2.08 billion, reached on 31 December 2021.NVO Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$826.80 M
+$44.15 M+5.64%
30 September 2024
Summary:
Novo Nordisk A/S quarterly short term debt is currently $826.80 million, with the most recent change of +$44.15 million (+5.64%) on 30 September 2024. Over the past year, it has dropped by -$109.80 million (-11.72%). NVO quarterly short term debt is now -60.31% below its all-time high of $2.08 billion, reached on 31 December 2021.NVO Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +355.8% | -11.7% |
3 y3 years | -22.0% | +292.6% |
5 y5 years | +1119.1% | +298.5% |
NVO Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -53.8% | +355.8% | -60.3% | +368.9% |
5 y | 5 years | -53.8% | +1119.1% | -60.3% | +368.9% |
alltime | all time | -53.8% | >+9999.0% | -60.3% | >+9999.0% |
Novo Nordisk A/S Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $826.80 M(+5.6%) |
June 2024 | - | $782.65 M(-46.8%) |
Mar 2024 | - | $1.47 B(+52.9%) |
Dec 2023 | $961.80 M(+355.8%) | $961.80 M(+2.7%) |
Sept 2023 | - | $936.59 M(+2.1%) |
June 2023 | - | $917.75 M(+401.2%) |
Mar 2023 | - | $183.13 M(-13.2%) |
Dec 2022 | $211.00 M(-89.9%) | $211.00 M(-12.9%) |
Sept 2022 | - | $242.27 M(+37.4%) |
June 2022 | - | $176.34 M(-15.8%) |
Mar 2022 | - | $209.49 M(-89.9%) |
Dec 2021 | $2.08 B(+69.0%) | $2.08 B(+889.1%) |
Sept 2021 | - | $210.62 M(+1.2%) |
June 2021 | - | $208.20 M(-80.6%) |
Mar 2021 | - | $1.08 B(-12.8%) |
Dec 2020 | $1.23 B(+457.9%) | $1.23 B(+432.6%) |
Sept 2020 | - | $231.47 M(+9.0%) |
June 2020 | - | $212.40 M(+15.6%) |
Mar 2020 | - | $183.72 M(-16.9%) |
Dec 2019 | $220.99 M(+180.1%) | $220.99 M(+6.5%) |
Sept 2019 | - | $207.50 M(+8.5%) |
June 2019 | - | $191.19 M(+14.2%) |
Mar 2019 | - | $167.41 M(+112.2%) |
Dec 2018 | $78.89 M(-71.1%) | $78.89 M(+50.5%) |
Sept 2018 | - | $52.43 M(+36.9%) |
June 2018 | - | $38.31 M(+1.6%) |
Mar 2018 | - | $37.69 M(-86.2%) |
Dec 2017 | $272.99 M(+738.3%) | $272.99 M(+563.4%) |
Sept 2017 | - | $41.15 M(-84.1%) |
June 2017 | - | $258.90 M(+194.0%) |
Mar 2017 | - | $88.06 M(+170.4%) |
Dec 2016 | $32.57 M(-79.3%) | $32.57 M(-52.5%) |
Sept 2016 | - | $68.63 M(+13.1%) |
June 2016 | - | $60.71 M(-1.7%) |
Mar 2016 | - | $61.73 M(-60.7%) |
Dec 2015 | $157.17 M(+33.7%) | $157.17 M(+65.4%) |
Sept 2015 | - | $95.03 M(-14.1%) |
June 2015 | - | $110.64 M(+28.5%) |
Mar 2015 | - | $86.11 M(-26.7%) |
Dec 2014 | $117.55 M(+195.4%) | $117.55 M(+142.8%) |
Sept 2014 | - | $48.41 M(-34.8%) |
June 2014 | - | $74.28 M(-49.8%) |
Mar 2014 | - | $148.04 M(+272.0%) |
Dec 2013 | $39.79 M(-55.1%) | $39.79 M(-67.2%) |
Sept 2013 | - | $121.22 M(-3.1%) |
June 2013 | - | $125.11 M(+142.6%) |
Mar 2013 | - | $51.56 M(-41.8%) |
Dec 2012 | $88.62 M(+44.9%) | $88.62 M(-13.0%) |
Sept 2012 | - | $101.81 M(+56.8%) |
June 2012 | - | $64.94 M(-5.3%) |
Mar 2012 | - | $68.54 M(+12.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $61.17 M(-80.1%) | $61.17 M(-80.2%) |
Sept 2011 | - | $308.81 M(+79.8%) |
June 2011 | - | $171.74 M(-10.0%) |
Mar 2011 | - | $190.80 M(-37.8%) |
Dec 2010 | $306.83 M(+281.6%) | $306.83 M(+67.7%) |
Sept 2010 | - | $182.98 M(-65.9%) |
June 2010 | - | $536.44 M(+185.4%) |
Mar 2010 | - | $187.93 M(+133.7%) |
Dec 2009 | $80.40 M(-68.0%) | $80.40 M(+78.4%) |
Sept 2009 | - | $45.06 M(-47.2%) |
June 2009 | - | $85.38 M(-66.9%) |
Mar 2009 | - | $257.94 M(+2.8%) |
Dec 2008 | $250.96 M(+217.6%) | $250.96 M(+65.1%) |
Sept 2008 | - | $152.04 M(+55.1%) |
June 2008 | - | $98.06 M(-24.9%) |
Mar 2008 | - | $130.64 M(+65.4%) |
Dec 2007 | $79.01 M(+31.8%) | $79.01 M(+172.6%) |
Sept 2007 | - | $28.98 M(+61.0%) |
June 2007 | - | $18.00 M(-48.6%) |
Mar 2007 | - | $35.00 M(-41.6%) |
Dec 2006 | $59.97 M(-73.8%) | $59.97 M(+17.6%) |
Sept 2006 | - | $51.00 M(-8.9%) |
June 2006 | - | $55.95 M(-70.7%) |
Mar 2006 | - | $190.79 M(-16.7%) |
Dec 2005 | $229.00 M(+146.5%) | $229.00 M(+66.0%) |
Sept 2005 | - | $137.92 M(+42.4%) |
June 2005 | - | $96.86 M(+30.8%) |
Mar 2005 | - | $74.04 M(-20.3%) |
Dec 2004 | $92.91 M(-43.7%) | $92.91 M(+27.2%) |
Sept 2004 | - | $73.02 M(-10.9%) |
June 2004 | - | $81.91 M(-37.4%) |
Mar 2004 | - | $130.91 M(-20.7%) |
Dec 2003 | $165.01 M(+106.4%) | $165.01 M(+106.4%) |
Dec 2002 | $79.93 M(-18.4%) | $79.93 M(-18.4%) |
Dec 2001 | $98.01 M(-3.9%) | $98.01 M(-3.9%) |
Dec 2000 | $102.01 M(-24.3%) | $102.01 M(-24.3%) |
Dec 1999 | $134.70 M(-6.9%) | $134.70 M(-6.9%) |
Dec 1998 | $144.65 M(-26.4%) | $144.65 M(-26.4%) |
Dec 1997 | $196.55 M(-13.6%) | $196.55 M(-13.6%) |
Dec 1996 | $227.43 M(+74.0%) | $227.43 M(+74.0%) |
Dec 1995 | $130.69 M(-45.4%) | $130.69 M(-45.4%) |
Dec 1994 | $239.22 M(+68.7%) | $239.22 M(+68.7%) |
Dec 1993 | $141.82 M(-11.0%) | $141.82 M(-11.0%) |
Dec 1992 | $159.33 M(-30.6%) | $159.33 M(-30.6%) |
Dec 1991 | $229.50 M(-22.8%) | $229.50 M(-22.8%) |
Dec 1990 | $297.39 M(+8.7%) | $297.39 M(+8.7%) |
Dec 1989 | $273.58 M(+49.4%) | $273.58 M(+49.4%) |
Dec 1988 | $183.09 M(+6.9%) | $183.09 M(+6.9%) |
Dec 1987 | $171.23 M(+1916.5%) | $171.23 M(+1916.5%) |
Dec 1986 | $8.49 M(+19.7%) | $8.49 M(+19.7%) |
Dec 1985 | $7.10 M(-91.8%) | $7.10 M(-91.8%) |
Dec 1984 | $86.36 M | $86.36 M |
FAQ
- What is Novo Nordisk A/S annual short term debt?
- What is the all time high annual short term debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual short term debt year-on-year change?
- What is Novo Nordisk A/S quarterly short term debt?
- What is the all time high quarterly short term debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly short term debt year-on-year change?
What is Novo Nordisk A/S annual short term debt?
The current annual short term debt of NVO is $961.80 M
What is the all time high annual short term debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual short term debt is $2.08 B
What is Novo Nordisk A/S annual short term debt year-on-year change?
Over the past year, NVO annual short term debt has changed by +$750.80 M (+355.83%)
What is Novo Nordisk A/S quarterly short term debt?
The current quarterly short term debt of NVO is $826.80 M
What is the all time high quarterly short term debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly short term debt is $2.08 B
What is Novo Nordisk A/S quarterly short term debt year-on-year change?
Over the past year, NVO quarterly short term debt has changed by -$109.80 M (-11.72%)